| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2971684 | The Journal of Heart and Lung Transplantation | 2012 | 6 Pages |
Abstract
Tacrolimus administered sublingually at approximately half of the oral dose achieves therapeutic blood concentrations and is safe in LTRs. Delivery via the sublingual route using this conversion ratio may aid clinicians in maintaining therapeutic tacrolimus blood concentrations while avoiding the need for intravenous administration.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Katherine D. PharmD, BCPS, Rebecca F. PharmD, Katherine M. PharmD, Lorriana E. MD, Jeffrey A. MD, Charles W. MD, Jonathan P. MD, MS,